Basilea Pharmaceutica
Basilea Pharmaceutica is a multinational specialty biopharmaceutical company headquartered in Basel, Switzerland. It was formed as a spin-off entity from the drug giant Hoffmann–La Roche in October 2000. It is engaged in the development of antibiotics, antifungals and oncology drugs for treatment of invasive aspergillosis and invasive mucormycosis. Basilea is publicly traded on the SIX Swiss exchange (SIX:BSLIN).
Wikipage disambiguates
primaryTopic
Basilea Pharmaceutica
Basilea Pharmaceutica is a multinational specialty biopharmaceutical company headquartered in Basel, Switzerland. It was formed as a spin-off entity from the drug giant Hoffmann–La Roche in October 2000. It is engaged in the development of antibiotics, antifungals and oncology drugs for treatment of invasive aspergillosis and invasive mucormycosis. Basilea is publicly traded on the SIX Swiss exchange (SIX:BSLIN).
has abstract
Basilea Pharmaceutica is a mul ...... sistant Staphylococcus aureus.
@en
Die Basilea Pharmaceutica AG i ...... Milliarden Schweizer Franken.
@de
founding year
industry
key person
location city
państwo
number of employees
thumbnail
type
Link from a Wikipage to an external page
Wikipage page ID
13,549,119
Wikipage revision ID
743,682,743
hypernym
comment
Basilea Pharmaceutica is a mul ...... IX Swiss exchange (SIX:BSLIN).
@en
Die Basilea Pharmaceutica AG i ...... Milliarden Schweizer Franken.
@de
label
Basilea Pharmaceutica
@de
Basilea Pharmaceutica
@en
wasDerivedFrom
depiction
homepage
isPrimaryTopicOf
name
Basilea Pharmaceutica AG
@en